FIGURE 3.
Recommended NTRK gene fusion testing algorithm for adult sarcomas, adapted from expert recommendations from the World Sarcoma Network. 44 (+)/(–): Presence/absence of NTRK gene fusions. †Please note that this is the opinion of the expert panel. Confirmation of NTRK gene fusions is required for TRK inhibitors. ‡For confirmation test, NGS is preferred, but FISH or RT‐PCR may be used if NGS is not accessible. Abbreviations: ALK, anaplastic lymphoma kinase; BRAF, v‐raf murine sarcoma viral oncogene homolog B; CDK4, cyclin‐dependent kinase 4; GIST, gastrointestinal stromal tumor; IHC, immunohistochemistry; KIT, v‐kit Hardy‐Zuckerman 4 feline sarcoma viral oncogene homolog; LPS, liposarcoma; MDM2, mouse double minute 2 homolog; NF1, neurofibromatosis type 1; NGS, next‐generation sequencing; NTRK, neurotrophic tyrosine receptor kinase; PDGFRA, platelet‐derived growth factor receptor alpha; ROS1, ROS proto‐oncogene 1, receptor tyrosine kinase; SDH, succinate dehydrogenase. *Specific histologies to look out for include, but are not limited to, lipofibromatosis‐like neural tumours, peripheral nerve sheath tumours, female reproductive organ sarcomas, undifferentiated sarcomas, osteosarcoma